申请人:Kissei Pharmaceutical Co Ltd
公开号:EP0303434A1
公开(公告)日:1989-02-15
Thiazolidine compounds of the general formula:
wherein Ar represents a phenyl group, a naphthyl group or a pyridyl group, Y represents a saturated or unsaturated alkylene group having 1 to 5 carbon atoms, n represents zero or 1,
represents a 5- or 6-membered saturated heterocyclic group which may contain a hetero atom other than the nitrogen atom, X represents an oxygen atom, m represents zero or 1, R represents a hydrogen atom or an alkoxycarbonyl group; and pharmaceutically acceptable salts thereof, possess an inhibitory effect for prolyl endopeptidase, and are useful as therapeutical agents for the treatment of dementia and amnesia.
通式如下的噻唑烷化合物
其中 Ar 代表苯基、萘基或吡啶基,Y 代表具有 1 至 5 个碳原子的饱和或不饱和亚 烷基,n 代表 0 或 1、
代表 5 或 6 元饱和杂环基团,该杂环基团可含有除氮原子之外的杂原子;X 代表氧原子;m 代表 0 或 1;R 代表氢原子或烷氧羰基;以及它们的药学上可接受的盐类,具有抑制脯氨酰内肽酶的作用,可用作治疗痴呆症和健忘症的治疗剂。